BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 38548868)

  • 1. Global epidemiology of epithelial ovarian cancer.
    Webb PM; Jordan SJ
    Nat Rev Clin Oncol; 2024 May; 21(5):389-400. PubMed ID: 38548868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the incidence of serous fallopian tube, ovarian, and peritoneal cancer in the US.
    Liao CI; Chow S; Chen LM; Kapp DS; Mann A; Chan JK
    Gynecol Oncol; 2018 May; 149(2):318-323. PubMed ID: 29514737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium.
    Wentzensen N; Poole EM; Trabert B; White E; Arslan AA; Patel AV; Setiawan VW; Visvanathan K; Weiderpass E; Adami HO; Black A; Bernstein L; Brinton LA; Buring J; Butler LM; Chamosa S; Clendenen TV; Dossus L; Fortner R; Gapstur SM; Gaudet MM; Gram IT; Hartge P; Hoffman-Bolton J; Idahl A; Jones M; Kaaks R; Kirsh V; Koh WP; Lacey JV; Lee IM; Lundin E; Merritt MA; Onland-Moret NC; Peters U; Poynter JN; Rinaldi S; Robien K; Rohan T; Sandler DP; Schairer C; Schouten LJ; Sjöholm LK; Sieri S; Swerdlow A; Tjonneland A; Travis R; Trichopoulou A; van den Brandt PA; Wilkens L; Wolk A; Yang HP; Zeleniuch-Jacquotte A; Tworoger SS
    J Clin Oncol; 2016 Aug; 34(24):2888-98. PubMed ID: 27325851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.
    Madsen C; Baandrup L; Dehlendorff C; Kjaer SK
    Acta Obstet Gynecol Scand; 2015 Jan; 94(1):86-94. PubMed ID: 25256594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salpingectomy as a means to reduce ovarian cancer risk.
    Daly MB; Dresher CW; Yates MS; Jeter JM; Karlan BY; Alberts DS; Lu KH
    Cancer Prev Res (Phila); 2015 May; 8(5):342-8. PubMed ID: 25586903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Fallopian Tubes in the Development of Ovarian Cancer.
    Corzo C; Iniesta MD; Patrono MG; Lu KH; Ramirez PT
    J Minim Invasive Gynecol; 2017 Feb; 24(2):230-234. PubMed ID: 28007588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 8. Extrauterine Pelvic Serous Carcinomas: Current Update on Pathology and Cross-sectional Imaging Findings.
    Katabathina VS; Amanullah FS; Menias CO; Chen MM; Valente PT; Chintapalli KN; Prasad SR
    Radiographics; 2016; 36(3):918-32. PubMed ID: 27163599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serous tubal intraepithelial carcinomas associated with high-grade serous ovarian carcinomas: a systematic review.
    Chen F; Gaitskell K; Garcia MJ; Albukhari A; Tsaltas J; Ahmed AA
    BJOG; 2017 May; 124(6):872-878. PubMed ID: 28218502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and outcomes of patients with stage I epithelial ovarian cancer compared with fallopian tube cancer.
    Rauh-Hain JA; Foley OW; Winograd D; Andrade C; Clark RM; Vargas RJ; Hinchcliff EM; Esselen KM; Horowitz NS; del Carmen MG
    Am J Obstet Gynecol; 2015 May; 212(5):600.e1-8. PubMed ID: 25514761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The morphological and immunohistochemical characteristics of changes in the fallopian tube mucosa in ovarian epithelial tumors].
    Asaturova AV; Ezhova LS; Faizullina NM; Sannikova MV; Khabas GN
    Arkh Patol; 2016; 78(2):3-9. PubMed ID: 27070769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global distribution pattern of histological subtypes of epithelial ovarian cancer: a database analysis and systematic review.
    Sung PL; Chang YH; Chao KC; Chuang CM;
    Gynecol Oncol; 2014 May; 133(2):147-54. PubMed ID: 24556058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of epithelial ovarian cancer.
    Webb PM; Jordan SJ
    Best Pract Res Clin Obstet Gynaecol; 2017 May; 41():3-14. PubMed ID: 27743768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.
    Kurman RJ; Shih IeM
    Hum Pathol; 2011 Jul; 42(7):918-31. PubMed ID: 21683865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and Nutrition.
    Ose J; Fortner RT; Rinaldi S; Schock H; Overvad K; Tjonneland A; Hansen L; Dossus L; Fournier A; Baglietto L; Romieu I; Kuhn E; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Masala G; Sieri S; Tumino R; Sacerdote C; Mattiello A; Ramon Quiros J; Obón-Santacana M; Larrañaga N; Chirlaque MD; Sánchez MJ; Barricarte A; Peeters PH; Bueno-de-Mesquita HB; Onland-Moret NC; Brändstedt J; Lundin E; Idahl A; Weiderpass E; Gram IT; Lund E; Kaw KT; Travis RC; Merritt MA; Gunther MJ; Riboli E; Kaaks R
    Int J Cancer; 2015 Jan; 136(2):399-410. PubMed ID: 24890047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salpingectomy for the Risk Reduction of Ovarian Cancer: Is It Time for a Salpingectomy-alone Approach?
    Boerner T; Long Roche K
    J Minim Invasive Gynecol; 2021 Mar; 28(3):403-408. PubMed ID: 33038519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory role of prohibitin in human ovarian epithelial cancer.
    Jia L; Ren JM; Wang YY; Zheng Y; Zhang H; Zhang Q; Kong BH; Zheng WX
    Int J Clin Exp Pathol; 2014; 7(5):2247-55. PubMed ID: 24966933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic salpingectomy for the prevention of ovarian cancer: Who should we target?
    Kotsopoulos J; Narod SA
    Int J Cancer; 2020 Sep; 147(5):1245-1251. PubMed ID: 32037528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hysterectomy with opportunistic salpingectomy versus hysterectomy alone.
    van Lieshout LAM; Steenbeek MP; De Hullu JA; Vos MC; Houterman S; Wilkinson J; Piek JM
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD012858. PubMed ID: 31456223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic inflammatory disease and risk of epithelial ovarian cancer: a national population-based case-control study in Sweden.
    Jonsson S; Jonsson H; Lundin E; Häggström C; Idahl A
    Am J Obstet Gynecol; 2024 Jan; 230(1):75.e1-75.e15. PubMed ID: 37778677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.